Fig. 10.
FI of the target tumor in the nude mice at 0 h, 5 min, 1, 2, 4, 8, 12, 24, 36 and 48 h (the tumor site in the dashed line cycle). a HeLa tumor-bearing nude mice + Ag2S@DP-FA; b HeLa tumor-bearing nude mice + Ag2S@DP; c A549 tumor-bearing nude mice + Ag2S@DP-FA; d A549 tumor-bearing nude mice + Ag2S@DP